HD-OPM Archive
Topics › Insulin resistance & diabetes

Metformin lowers glucose partly through a hypothalamic Rap1 brain pathway

Louis Nervegna · May 08, 2026 · ♥ 4 reactions · 5 comments · original Facebook post
Insulin resistance & diabetesBrain health & dementia
AI summary & key facts

Quoted summary of a Science Advances paper suggesting metformin's glucose-lowering effect depends partly on Rap1 signaling in the hypothalamus, not only the liver and gut as long assumed.

Metformin lowers blood glucose, in part, through a newly discovered mechanism in the brain.

Quoted:

For over 60 years, we thought metformin worked mainly through the liver and gut.
But new research suggests the brain may play a major role too.

This study identified a specific brain pathway (Rap1 in the hypothalamus) that appears critical to metformin's glucose-lowering effects, potentially reshaping how we understand one of the world's most prescribed diabetes medications.

Source: Sci. Adv. 2025;11:eadu3700

#metforminHD #brainHD #rap1HD #hypothalamusHD

Research cited

← newer: The EWG 'Dirty Dozen' list ignores dose, and conventional prolder: Eggs do not raise TMAO, but choline bitartrate supplements d →